MIAMI, Feb. 13, 2023 – PRESS RELEASE – Ayr Wellness Inc., a leading vertically integrated U.S. multistate cannabis operator, announced that Jonathan Sandelman has transitioned to executive chair, where he will continue to serve the company’s board of directors, and David Goubert, current President of Ayr, has assumed the role of President and CEO.
“I am pleased to announce today’s exciting news for Ayr,” Sandelman said. “It is with great pride that I reflect on the efforts of our team to build Ayr from its earliest days in 2017 to the 2,500-person multistate cannabis operator we are today. David is a proven leader of people and large organizations, with a track record of driving positive organizational change. In his time so far at Ayr, he has brought a fresh set of eyes to our organization and processes and has set us on the path to optimizing the business and investing in projects that will result in our long-term success.
“It has been an honor and a privilege to lead this great company as CEO, and I know Ayr is in very capable hands with David’s leadership and the depth of experience of Ayr’s executive team, as well as the passion and commitment of the entire Ayr team across the country. Thanks to their hard work and dedication we have built a strong foundation for our business that is well positioned to pursue further growth in the cannabis industry, and to serve as a force for good in our communities. I am confident that Ayr is well positioned for its next phase of growth and profitability.”
Goubert said, “I’m proud and humbled to take this step at an important time in the company’s history. I look forward to continuing to work closely with Jon, the board of directors, and everyone at Ayr to realize the full potential of our company’s exceptional assets, continuing to prioritize existing and future markets where we can invest to build meaningful depth. In my time so far with Ayr, I have been excited by our team’s collaborative efforts to align our organization with our key business objectives, deepen our relationships with our patients as we build Ayr into a truly customer-centric business, and in doing so drive strong revenue and cash flow generation. We look forward to discussing our plans in further detail during the next quarterly earnings call in March.”
